William L. Macias, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 16,212 shares at $29.94 ($471K) on 2024-04-17, disclosed to the SEC on 2024-04-19.
Open-market sale of $471k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 269 | $8K | 1.6% |
| 2 | $28.80 | 6,136 | $177K | 37.5% |
| 3 | $28.80 | 6,136 | $177K | 37.5% |
| 4 | $29.94 | 79 | $2K | 0.5% |
| 5 | $29.94 | 1,796 | $54K | 11.4% |
| 6 | $29.94 | 1,796 |
| $54K |
| 11.4% |
| Total | $29.06 avg | 16,212 | $471K | 100% |
| Filing → |
| IMVT | SELL | 2024-11-22 | $171K | — | Filing → |
| IMVT | SELL | 2024-10-18 | $167K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $189K | — | Filing → |